BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2651 related articles for article (PubMed ID: 9265238)

  • 1. [The effect of hemodialysis and continuous ambulatory peritoneal dialysis on renal anemia].
    Stojimirović B; Grujić-Adanja G
    Srp Arh Celok Lek; 1997; 125(5-6):163-7. PubMed ID: 9265238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of the number of peritonitis episodes on peritoneal membrane function].
    Jovanović D; Nesić V; Dimitrijević Z
    Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of bolus intraperitoneal iron dextran in continuous ambulatory peritoneal dialysis or continuous cyclic peritoneal dialysis patients receiving recombinant human erythropoietin.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 1999; 15():60-4. PubMed ID: 10682073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Renal anemia and the effect of long-term dialysis].
    Opatrná S; Opatrný K
    Cas Lek Cesk; 1999 Feb; 138(4):107-10. PubMed ID: 10376407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid deficiency modifies the haematopoietic response to recombinant human erythropoietin in maintenance dialysis patients.
    Schiffl H; Lang SM
    Nephrol Dial Transplant; 2006 Jan; 21(1):133-7. PubMed ID: 16144854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous ambulatory peritoneal dialysis: three years' experience.
    Ramos JM; Gokal R; Siamopolous K; Ward MK; Wilkinson R; Kerr DN
    Q J Med; 1983; 52(206):165-86. PubMed ID: 6611839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
    Korbet SM
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Erythropoietin treatment of dialysis patients].
    Stenver DI; Nielsen B
    Ugeskr Laeger; 1994 Apr; 156(17):2589-91. PubMed ID: 8016967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
    Ifudu O; Feldman J; Friedman EA
    N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneal dialysis in the aged].
    Stojimirović B; Nesić V; Dimitrijević Z; Jovanović N
    Med Pregl; 1999; 52(9-10):369-74. PubMed ID: 10624386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors influencing anaemia in dialysis patients. A special survey by the EDTA-ERA Registry.
    Geerlings W; Morris RW; Brunner FP; Brynger H; Ehrich JH; Fassbinder W; Rizzoni G; Selwood NH; Tufveson G; Wing AJ
    Nephrol Dial Transplant; 1993; 8(7):585-9. PubMed ID: 8396740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anemia in patients on continuous ambulatory peritoneal dialysis (CAPD)].
    Tokuda Y; Itou H; Uchida Y; Azuma K; Ohtsuka H; Uomizu K; Yamashita W; Harada R; Nakashima A; Morita T
    Fukuoka Igaku Zasshi; 1989 Jul; 80(7):379-84. PubMed ID: 2807127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction of anaemia in haemodialysis patients with recombinant human erythropoietin.
    Boran M; Dalva I; Yazicioğlu A; Akbay E; Cetin S
    Int Urol Nephrol; 1993; 25(2):197-203. PubMed ID: 8365853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoiesis in the anaemia of chronic renal failure: the response to CAPD.
    Coles GA; Cavill I
    Nephrol Dial Transplant; 1986; 1(3):170-4. PubMed ID: 3110671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential role of parathyroid hormone as an inhibitor of erythropoiesis in the anemia of renal failure.
    McGonigle RJ; Wallin JD; Husserl F; Deftos LJ; Rice JC; O'Neill WJ; Fisher JW
    J Lab Clin Med; 1984 Dec; 104(6):1016-26. PubMed ID: 6501997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT; Prata MM; Barbas JV; dos Santos JP
    Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life of patients having renal replacement therapy.
    Niu SF; Li IC
    J Adv Nurs; 2005 Jul; 51(1):15-21. PubMed ID: 15941456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of residual renal function in patients undergoing maintenance haemodialysis or continuous ambulatory peritoneal dialysis.
    Rottembourg J; Issad B; Gallego JL; Degoulet P; Aime F; Gueffaf B; Legrain M
    Proc Eur Dial Transplant Assoc; 1983; 19():397-403. PubMed ID: 6878254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 133.